ASCO 2022 | Promising future of PSMA for prostate cancer

Eugene Shenderov, MD, PhD, Johns Hopkins Medicine, Baltimore, MD, discusses the hot topics in prostate cancer at ASCO 2022, including the development of immunotherapies and the rise of PSMA in the management of prostate cancer. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.